Author:
Zhang Dan,Guo Rui,Lei Lei,Liu Hongjuan,Wang Yawen,Wang Yili,Qian Hongbo,Dai Tongxin,Zhang Tianxiao,Lai Yanjun,Wang Jingya,Liu Zhiqiang,Chen Tianyan,He Aili,O’Dwyer Michael,Hu Jinsong
Abstract
AbstractBackgroundExcessive monocyte/macrophage activation with the development of a cytokine storm and subsequent acute lung injury, leading to acute respiratory distress syndrome (ARDS) is a feared consequence of infection with COVID-19. The ability to recognize and potentially intervene early in those patients at greatest risk of developing this complication could be of great clinical utility.MethodsWe performed detailed flow cytometric analysis of peripheral blood samples from 28 COVID-19 patients treated at Xian No.8 Hospital and the First Affiliated Hospital of Xian Jiaotong University in early 2020 in an attempt to identify factors that could help predict severity of disease and patient outcome.FindingsWhile we did not detect significant differences in the number of monocytes between patients with COVID-19 and normal healthy individuals,we did identify significant morphological and functional differences, which are more pronounced in patients requiring prolonged hospitalization and ICU admission. Patients with COVID-19 have larger than normal monocytes, easily identified on forward scatter, side scatter analysis by routine flow cytometry,with the presence of a distinct population of monocytes with high forward scatter (FSC-high). On more detailed analysis, these FSC-high monocytes are CD11b+, CD14+, CD16+, CD68+, CD80+, CD163+, CD206+ and secrete IL-6, IL-10 and TNF-alpha, consistent with an inflammatory phenotype.ConclusionsThe detection and serial monitoring of this subset of inflammatory monocytes using flow cytometry could be of great help in guiding the prognostication and treatment of patients with COVID-19 and merits further evaluation.
Publisher
Cold Spring Harbor Laboratory
Reference25 articles.
1. A Novel Coronavirus from Patients with Pneumonia in China, 2019
2. Guan WJ , Ni ZY , Hu Y , et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine 2020.
3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Lancet (London, England),2020
4. Zhou F , Yu T , Du R , et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 2020.
5. Qin C , Zhou L , Hu Z , et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2020.
Cited by
93 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献